ICR.AX
The company's capital structure is highly leveraged, with total liabilities of AUD 1.86 billion and total equity of negative AUD 833.17 million, resulting in a debt-to-equity ratio of -0.86. Despite holding AUD 410.53 million in cash and equivalents, the company's liquidity position is constrained by its operating cash flow of -AUD 1.67 billion and free cash flow of -AUD 2.16 billion, contributing to a current ratio of 0.47. This suggests a medium liquidity risk, as the company's short-term obligations may not be fully covered by its current assets. Profitability metrics indicate significant underperformance relative to industry norms. The company reported a net loss of AUD 2.24 billion and an operating loss of AUD 2.16 billion, with a return on assets of -2.1962 and a return on equity of 2.6936. These figures suggest that the company is not generating returns that cover its cost of capital, which is a critical concern for long-term sustainability. The company's revenue of AUD 1.58 billion is derived from a mix of product sales and service offerings, though the exact segment breakdown is not disclosed. There is no available data on geographic exposure or revenue concentration, making it difficult to assess the company's risk from regional or customer concentration. Looking ahead, the company is expected to continue facing financial challenges. The operating loss and negative cash flows suggest a lack of growth momentum, and there is no indication of a turnaround in the near term. The company's capital expenditure of -AUD 7,090 indicates minimal investment in growth, which may further limit its ability to improve performance. The risk assessment highlights a key flag: the company's net cash position is negative after subtracting total debt, indicating a liquidity risk. While the dilution risk is currently low, the company's negative equity and high debt levels could lead to future dilution if it needs to raise additional capital. No recent events or filings have been disclosed that would provide further insight into the company's strategic direction or financial health.
Business. ICR.AX provides integrated hardware and software solutions for the healthcare technology sector, primarily generating revenue through product sales and service offerings.
Classification. ICR.AX is classified under the Technology sector, specifically in the Technology Equipment business sector, with a high confidence level of 0.92.
- ICR.AX is operating at a significant loss, with a net income of -AUD 2.24 billion and an operating loss of -AUD 2.16 billion.
- The company's liquidity position is weak, with a current ratio of 0.47 and negative free cash flow of -AUD 2.16 billion.
- The debt-to-equity ratio of -0.86 indicates a highly leveraged capital structure, which increases financial risk.
- The company's return on assets is negative at -2.1962, suggesting poor asset utilization and underperformance relative to industry standards.
- There is no clear indication of growth or improvement in the company's financial performance in the near term.
- Net cash is negative after subtracting total debt.